Alliance Global signs exclusive distribution agreement with BioLegend

July, 2020 – BioLegend, Inc., a leading manufacturer and supplier of antibodies and reagents that covers a diverse set of research areas including immunology, cancer research, neuroscience, proteogenomics, stem cells, and other emerging sectors, has signed an exclusive distribution agreement with Alliance Global (AGBL) Group.

“BioLegend is continually expanding its product offerings globally. AGBL is an important new strategic partner in emerging markets”, stated Craig Monell, Senior VP, Business Operations at BioLegend.

AGBL Sales Director, Fady Al Assaly, expressed his contentment with this “We are always seeking to bring the best products and service to our customers, we believe  that BioLegend products will complement our range of cell biology and flow cytometry range of products and will enrich our offering to our customers in the region.”

Please read the Press release https://bit.ly/30KLAt2

2020-07-27T17:43:00+00:00 July 20th, 2020|Categories: News|0 Comments